Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  HIV Infection

  Free Subscription

Articles published in JAMA

Retrieve available abstracts of 56 articles:
HTML format

Single Articles

    December 2023
  1. ROSE MR, Chida NM, Jones JL
    Fourth-Generation HIV Testing.
    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.18137.

    JAMA. 2023 Dec 1. doi: 10.1001/jama.2023.25077.

    November 2023
  3. CHEN TL, Chuang HK, Wu CY
    Violaceous Nodules on the Right Leg and Foot.
    JAMA. 2023 Nov 20. doi: 10.1001/jama.2023.20118.

    October 2023
    Trial Launches of New HIV Vaccine Candidate With CMV Vector.
    JAMA. 2023 Oct 4. doi: 10.1001/jama.2023.19203.

    September 2023
  5. GANDHI M, Goosby E
    PEPFAR Reauthorization by Congress Urgent for Global Health.
    JAMA. 2023 Sep 14. doi: 10.1001/jama.2023.19322.

    Many Medicaid Enrollees Do Not Receive Needed HIV Care.
    JAMA. 2023 Sep 13. doi: 10.1001/jama.2023.17174.

    August 2023
  7. LIU AY, Scott HM, Buchbinder SP
    New USPSTF Guidelines for HIV Preexposure Prophylaxis: Will More Choices Lead to Greater Impact?
    JAMA. 2023;330:699-701.

  8. Preventing HIV With PrEP.
    JAMA. 2023;330:777-778.

  9. CHOU R, Spencer H, Bougatsos C, Blazina I, et al
    Preexposure Prophylaxis for the Prevention of HIV: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2023;330:746-763.
    PubMed     Abstract available

  10. BARRY MJ, Nicholson WK, Silverstein M, Chelmow D, et al
    Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2023;330:736-745.
    PubMed     Abstract available

    June 2023
  11. NKENGASONG J, Zaidi I, Katz IT
    PEPFAR at 20-Looking Back and Looking Ahead.
    JAMA. 2023 Jun 9. doi: 10.1001/jama.2023.9291.

  12. HARRIS E
    Decline in New HIV Cases Projected to Fall Short of US Goals.
    JAMA. 2023 Jun 7. doi: 10.1001/jama.2023.9924.

    May 2023
  13. HARRIS E
    HIV Status Not Linked to Treatment Outcomes for People With Mpox.
    JAMA. 2023 May 3. doi: 10.1001/jama.2023.7767.

  14. HARRIS E
    Urine Tests May Miss More Than 400 000 STIs in the US Every Year.
    JAMA. 2023;329:1443.

    April 2023
  15. HARRIS E
    Daily Statin Trial for People With HIV Halted Early for Clear Benefit.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6619.

  16. HARRIS E
    STI Epidemic Worsened in 2021, Syphilis Cases Surged.
    JAMA. 2023 Apr 26. doi: 10.1001/jama.2023.6620.

  17. HARRIS E
    World on Path to Eliminate AIDS as a Global Threat by 2030.
    JAMA. 2023;329:1248.

  18. GLUCK AR, Gostin LO
    Cost-Free Preventive Care Under the ACA Faces Legal Challenge.
    JAMA. 2023 Apr 10. doi: 10.1001/jama.2023.6584.

  19. BAROCAS JA, Nall SK, Axelrath S, Pladsen C, et al
    Population-Level Health Effects of Involuntary Displacement of People Experiencing Unsheltered Homelessness Who Inject Drugs in US Cities.
    JAMA. 2023 Apr 10. doi: 10.1001/jama.2023.4800.
    PubMed     Abstract available

  20. EKE AC, Lockman S, Mofenson LM
    Antiretroviral Treatment of HIV/AIDS During Pregnancy.
    JAMA. 2023 Apr 3. doi: 10.1001/jama.2023.5076.

    March 2023
  21. HARRIS E
    First HIV Remission in Patient Treated With Stem Cells From Cord Blood.
    JAMA. 2023 Mar 22. doi: 10.1001/jama.2023.4008.

  22. HARRIS E
    Severe Form of Mpox Identified in Patients With Advanced HIV.
    JAMA. 2023 Mar 8. doi: 10.1001/jama.2023.3191.

  23. RUBIN R
    Highlights From CROI, the Conference on Retroviruses and Opportunistic Infections-Postexposure Prophylaxis for Sexually Transmitted Infections, a New Protease Inhibitor for COVID-19, Goals for Preventing HIV Transmission, and More.
    JAMA. 2023 Mar 1. doi: 10.1001/jama.2023.0158.

    February 2023
  24. SURAN M
    New HIV Vaccine Approach Safely Stimulated Rare Precursors to Broadly Neutralizing Antibodies.
    JAMA. 2023 Feb 1. doi: 10.1001/jama.2022.23242.

    January 2023
  25. ZALLA LC, Cole SR, Eron JJ, Adimora AA, et al
    Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US.
    JAMA. 2023;329:52-62.
    PubMed     Abstract available

    December 2022
  26. KELS CG
    Consent Laws for Minors Regarding Sexually Transmitted Infection and HIV Services.
    JAMA. 2022;328:2363-2364.

  27. UNDERHILL K, Nelson KM
    Consent Laws for Minors Regarding Sexually Transmitted Infection and HIV Services-Reply.
    JAMA. 2022;328:2364.

  28. KUEHN BM
    Early Treatment Recommended for Patients With HIV and Monkeypox.
    JAMA. 2022;328:2203.

  29. HADDAD M, Person AK, Tookes HE
    Ending the HIV Epidemic: We Have the Tools, Do We Have the Will?
    JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22569.

  30. GANDHI RT, Bedimo R, Hoy JF, Landovitz RJ, et al
    Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.
    JAMA. 2022 Dec 1. doi: 10.1001/jama.2022.22246.
    PubMed     Abstract available

    November 2022
  31. SURAN M
    Highlights From Infectious Disease Week 2022-COVID-19, HIV, Monkeypox, and Polio.
    JAMA. 2022 Nov 9. pii: 2798547. doi: 10.1001/jama.2022.17754.

    October 2022
  32. JOHNSTON C, Magaret A, Son H, Stern M, et al
    Viral Shedding 1 Year Following First-Episode Genital HSV-1 Infection.
    JAMA. 2022 Oct 22. pii: 2797619. doi: 10.1001/jama.2022.19061.
    PubMed     Abstract available

    An Association Between Heavy Rainfall and HIV in Sub-Saharan Africa.
    JAMA. 2022;328:1490.

  34. WULF HANSON S, Abbafati C, Aerts JG, Al-Aly Z, et al
    Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.
    JAMA. 2022 Oct 10. pii: 2797443. doi: 10.1001/jama.2022.18931.
    PubMed     Abstract available

    September 2022
  35. KUEHN BM
    Interim Guidance for Monkeypox Among Patients With HIV.
    JAMA. 2022;328:1173-1174.

    HIV, Subclinical Cardiovascular Disease, and Clinical Progression: Insights From Immunologic Heterogeneity.
    JAMA. 2022;328:931-932.

  37. HUDSON JA, Majonga ED, Ferrand RA, Perel P, et al
    Association of HIV Infection With Cardiovascular Pathology Based on Advanced Cardiovascular Imaging: A Systematic Review.
    JAMA. 2022;328:951-962.
    PubMed     Abstract available

    August 2022
  38. NELSON KM, Skinner A, Underhill K
    Minor Consent Laws for Sexually Transmitted Infection and HIV Services.
    JAMA. 2022;328:674-676.

  39. KUEHN BM
    Reduced HIV Testing and Diagnoses During COVID-19 Pandemic.
    JAMA. 2022;328:519.

    July 2022
    Dual Anti-HIV Antibodies Provide Long-term Viral Suppression.
    JAMA. 2022;328:122.

    May 2022
  41. MCCLYMONT E, Albert AY, Alton GD, Boucoiran I, et al
    Association of SARS-CoV-2 Infection During Pregnancy With Maternal and Perinatal Outcomes.
    JAMA. 2022 May 2. pii: 2792031. doi: 10.1001/jama.2022.5906.
    PubMed     Abstract available

    April 2022
  42. RUOPP NF, Cockrill BA
    Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
    JAMA. 2022;327:1379-1391.
    PubMed     Abstract available

    First Condom Authorized Specifically for Anal Intercourse.
    JAMA. 2022;327:1219.

    March 2022
  44. MAYER KH, Allan-Blitz LT
    Enhancing HIV Prevention With New Modalities and Routine Sexual History Discussions.
    JAMA. 2022 Mar 28. pii: 2790710. doi: 10.1001/jama.2022.3848.

  45. COREY L, Corbett-Detig R, Beyrer C
    Expanding Efforts and Support to Respond to the HIV and COVID-19 Intersecting Pandemics.
    JAMA. 2022 Mar 11. pii: 2790239. doi: 10.1001/jama.2022.3517.

  46. ABBASI J
    First mRNA HIV Vaccine Clinical Trial Launches.
    JAMA. 2022;327:909.

    February 2022
  47. PATEL EU, Genberg BL, Zhu X, Krawczyk N, et al
    HIV and Hepatitis C Virus Testing and Treatment Services in Specialty Treatment Facilities That Offer Medication for Opioid Use Disorder in the US.
    JAMA. 2022;327:776-777.

  48. SHARFSTEIN JM, Killelea A, Dangerfield D
    Long-Acting Cabotegravir for HIV Prevention: Issues of Access, Cost, and Equity.
    JAMA. 2022 Feb 14. pii: 2789293. doi: 10.1001/jama.2022.0420.

    January 2022
  49. CHRISTENSEN BW, Li HC, Huerta S
    Blurred Vision and Gastrointestinal Bleeding in a Patient With HIV.
    JAMA. 2022;327:276-277.

  50. MAFI JN, Craff M, Vangala S, Pu T, et al
    Trends in US Ambulatory Care Patterns During the COVID-19 Pandemic, 2019-2021.
    JAMA. 2022;327:237-247.
    PubMed     Abstract available

  51. KUEHN BM
    Global HIV Suppression Rates Fall Short of Targets.
    JAMA. 2022;327:209.

  52. TUDDENHAM S, Hamill MM, Ghanem KG
    Diagnosis and Treatment of Sexually Transmitted Infections: A Review.
    JAMA. 2022;327:161-172.
    PubMed     Abstract available

    December 2021
  53. RUBIN R
    Questions Remain About Who Will Get Monoclonal Antibodies for COVID-19 Preexposure Prophylaxis.
    JAMA. 2021 Dec 29. pii: 2787758. doi: 10.1001/jama.2021.23557.

    November 2021
  54. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar.
    JAMA. 2021 Nov 1. pii: 2785918. doi: 10.1001/jama.2021.19623.
    PubMed     Abstract available

    October 2021
  55. KUEHN BM
    COVID-19 Rolls Back Progress Against HIV, TB, and Malaria.
    JAMA. 2021;326:1471.

    September 2021
  56. ZUGER A
    Preventing a Pandemic's Toll-We've Been Here Before.
    JAMA. 2021;326:909-910.

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.